ITMCTR2200005546
Completed
Phase 1
A Randomized Controlled Study of Fire Needle Combined with TCM Decoction in Intervention of Non-puerperal Mastitis with Heat and Meat Rot Syndrome in Abscess Period
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Conditionson-puerperal Mastitis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- on-puerperal Mastitis
- Sponsor
- onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Meet the expert consensus diagnostic criteria for NPM, and the TCM syndrome differentiation is the heat\-filled meat rot syndrome;
- •? NPM with abscesses as the predominant, and superficial abscesses;
- •? Physical examination can palpate the fluctuation of the obvious breast lump area, and the range of abscess can be shown on the breast color Doppler ultrasound;
- •?The breast abscess is not healed after the breast abscess collapses on its own or after the operation.
- •? Voluntarily accept fire acupuncture treatment and visit, and sign the informed consent form
Exclusion Criteria
- •? NPM simple mass stage;
- •? pregnant or breastfeeding women;
- •? Combined with benign breast tumors, breast cancer and other breast diseases;
- •? Combined with cardiovascular and cerebrovascular diseases, abnormal liver and kidney function, diabetes or mental diseases;
- •? Patients who do not accept fire needles or suffer from needle dizziness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Clinical observation of fire needle combined with halometasone cream in the treatment of acral vitiligoVitiligoITMCTR2100004789Dermatology Hospital,Southern Medical University
Recruiting
Phase 1
Clinical safety evaluation of He's fire needleClinical safety of fire needleITMCTR1900002702Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Completed
Phase 2
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcomasoft tissue cancer10072990NL-OMON39691Morphotek, Inc10
Active, not recruiting
Phase 1
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.EUCTR2012-001399-12-NLMorphotek Inc.200
Active, not recruiting
Phase 1
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.Metastatic Soft Tissue SarcomaMedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001399-12-BEMorphotek Inc.200